Use of orally absorbable motilin preparations to enhance motilit

Details Use of orally absorbable motilin preparations to enhance motilit Use of orally absorbable motilin preparations to enhance motilit

1993-09-08

1995-11-21

Warden, Jill

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 13, A61K 3800, C07K 500, C07K 700, C07K 1700

Patent

active

054687284

ABSTRACT:
A readily absorbable type of motilin preparation containing a motilin-like active substance and a surface active agent is provided, in which the motilin-like active substance is mainly L-leucine-13-motilin-homoserine, and the surface active agent is selected from the group consisting of a bile salt, saponin and a polyethylene glycol higher-alcohol ether for nasal administration purposes and is a peptide lytic enzyme inhibitor for oral administration purposes.

REFERENCES:
patent: 4917893 (1990-04-01), Okada et al.
patent: 5011824 (1991-04-01), Masada et al.
Database WPIL, Section Ch, Week 9240, Derwent Publications Ltd., London, GB; Class B04, AN 92-328095 & JP-A-4 235 923 (Kyowa Hakko Kogyo KK), Aug. 25, 1992.

Affiliated with

Also associated with

Rating

Use of orally absorbable motilin preparations to enhance motilit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of orally absorbable motilin preparations to enhance motilit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of orally absorbable motilin preparations to enhance motilit will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1137162